Skip to main content
Aurora Cannabis Inc. logo

Aurora Cannabis Inc. — Investor Relations & Filings

Ticker · ACB ISIN · CA05156X8504 TSX Manufacturing
Filings indexed 364 across all filing types
Latest filing 2026-05-21 Regulatory Filings
Country CA Canada
Listing TSX ACB

About Aurora Cannabis Inc.

https://www.auroramj.com/

Aurora Cannabis Inc. is a global leader in the production and distribution of cannabis and cannabis-derivative products. The company cultivates and sells a portfolio of products for both medicinal and recreational markets. Recognized as Canada's largest medical cannabis company and a trusted provider, Aurora focuses on innovative, science-based medical cannabis offerings, including dried flower and various derivative formats such as oils and edibles. The company maintains operations across 12 countries, emphasizing high-quality cultivation and rigorous product development to serve patients and consumers worldwide.

Recent filings

Filing Released Lang Actions
Notice of the meeting and record date - English.pdf
Regulatory Filings Classification · 85% confidence The document is a notice from the company’s transfer agent to Canadian securities regulators detailing the mechanics of the upcoming Annual General Meeting (record dates, NAA requirements, meeting format). It does not include AGM materials or a full proxy statement sent to shareholders, nor is it a report publication or voting results. This is a general regulatory compliance notification, placing it in the fallback Regulatory Filings category.
2026-05-21 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a corporate press release announcing the grant of Plant Breeders’ Rights for two proprietary cannabis cultivars. It contains no financial statements, no management or board changes, no earnings results, no investor presentation slides, and no substantive regulatory or legal report. It is a general announcement and does not constitute a financial report or proxy or other specific filing type. Therefore it falls under the general “Regulatory Filings” fallback category (RNS).
2026-05-14 English
News release - English.pdf
Regulatory Filings
2026-04-28 English
Material change report - English.pdf
M&A Activity Classification · 88% confidence The document is a Form 51-102F3 Material Change Report filed under Canadian securities rules, announcing that a wholly owned subsidiary of Aurora Cannabis has purchased 100% of the shares of Safari Flower Company for $26.5 million. This is a corporate acquisition transaction (an M&A event) rather than a routine earnings release, dividend notice, or board change. It falls under the “Announcements and documents related to merger proposals or takeover bids” category. Therefore, it should be classified as M&A Activity (TAR).
2026-04-16 English
Material change report - English.pdf
Regulatory Filings Classification · 85% confidence The document is a brief consent letter of a Qualified Person approving the public filing of an NI 43-101 Technical Report. It is not the technical report itself, nor an AGM, earnings release, management change, or other specific category. It serves as a regulatory filing requirement for securities disclosure. No precise category exists for NI 43-101 consents, so it falls into the fallback “Regulatory Filings” category (RNS).
2026-04-16 English
Material change report - English.pdf
M&A Activity Classification · 90% confidence The document is a Form 51-102F3 “Material Change Report” filed by Aurora Cannabis Inc. under Canadian securities rules, describing the acquisition of 100% of the shares of Safari Flower Company. This is a definitive M&A transaction announcement. Under our taxonomy, announcements and documents related to mergers, acquisitions, or takeover bids fall under M&A Activity (Code: TAR).
2026-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.